Company Performance - Oscar Health, Inc. (OSCR) closed at $21.03, reflecting a +1.74% increase from the previous day, outperforming the S&P 500's daily loss of 0.63% [1] - Prior to the latest trading session, shares had gained 16.32%, contrasting with the Finance sector's loss of 0.83% and the S&P 500's gain of 0.92% [1] Upcoming Earnings - The company's earnings report is scheduled for November 6, 2025, with an expected EPS of -$0.55, representing a 150% decline from the prior-year quarter [2] - The Zacks Consensus Estimate projects net sales of $3.09 billion, indicating a 27.51% increase from the year-ago period [2] Full Year Projections - For the full year, the Zacks Consensus Estimates forecast earnings of -$1.42 per share and revenue of $12.06 billion, reflecting changes of -1520% and +31.44% respectively from the prior year [3] Analyst Estimates - Recent changes to analyst estimates for Oscar Health, Inc. are important as they reflect short-term business trends [4] - Positive revisions in estimates indicate analysts' confidence in the company's performance and profit potential [4] Zacks Rank System - The Zacks Rank system, which ranges from 1 (Strong Buy) to 5 (Strong Sell), has a history of outperforming, with 1 stocks returning an average annual gain of +25% since 1988 [6] - Over the last 30 days, the Zacks Consensus EPS estimate for Oscar Health, Inc. has decreased by 0.23%, and the company currently holds a Zacks Rank of 4 (Sell) [6] Industry Overview - Oscar Health, Inc. operates within the Insurance - Multi line industry, which is part of the Finance sector [7] - The current Zacks Industry Rank for this sector is 68, placing it in the top 28% of over 250 industries [7]
Oscar Health, Inc. (OSCR) Advances While Market Declines: Some Information for Investors